EP Patent

EP0598309A2 — Multilayer matrix systems for the controlled release of active principles

Assigned to Sanofi SRL · Expires 1994-05-25 · 32y expired

What this patent protects

This invention concerns systems for the release of active principles which are capable of releasing active principle(s) into an aqueous medium at a controlled rate. More precisely, the invention concerns a monolithic system for the controlled release of active principles, c…

USPTO Abstract

This invention concerns systems for the release of active principles which are capable of releasing active principle(s) into an aqueous medium at a controlled rate. More precisely, the invention concerns a monolithic system for the controlled release of active principles, consisting of: a) at least one swelling layer containing one or more active principles, in a matrix of swellable, hydrophilic polymers; b) at least one erodible and/or soluble layer comprising excipients and/or water soluble polymers, possibly containing one or more active principles, either the same or different from those present in the layer a), the said erodible and/or soluble layer being in contact with the swelling layer(s) a).

Drugs covered by this patent

Patent Metadata

Patent number
EP0598309A2
Jurisdiction
EP
Classification
Expires
1994-05-25
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.